# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early preca...
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...
Lucid Diagnostics had cash and cash equivalents of $18.9 million as of December 31, 2023, compared to $22.5 million as of Decem...